A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3.
Oleanolic Acid (OA) is a nature product extracted from Chinese Herb Medicine which is traditionally used as treatment of diabetes and ischemic heart diseases. Mounting evidence showed that AMP-activated protein kinase (AMPK) has cardioprotective effect against ischemic injury and the forkhead transcription factor 3 (FOXO3) was recently identified as a downstream target of AMPK. We hypothesize that OA may protect against ischemic dysfunction of cardiomyocytes via activation of AMPK signaling pathway. Male C57BL/6 mice which were subjected to in vivo regional cardiac ischemia stimulated AMPK Thr(172) phosphorylation, as well as phosphorylation of downstream FOXO3 (Ser(413)) and acetyl CoA carboxylase (ACC). The natural product, OA, significantly stimulated cardiac AMPK activation in cardiomyocyes in time- and dose-dependent manners. The mechanism of AMPK activation by OA may be due to the loss mitochondrial membrane potential (Deltapsim) as shown by JC-1 fluorescence assay. Intriguingly, OA as an AMPK activator also triggered FOXO3 (Ser(413)) phosphorylation in cardiomyocytes. Furthermore, OA treatment can protect cardiomyocytes from contractile dysfunction induced by hypoxia. Taken together, the results indicated that both ischemia and OA stimulated cardiac AMPK phosphorylation, as well downstream FOXO3 phosphorylation. The cardioprotective effect of OA maybe associated with activation of AMPK signaling pathways.
Wang
Jingying
J
Division of Pharmaceutical Sciences & Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, School of Pharmacy, Laramie, WY 82071.
Ma
Heng
H
Zhang
Xiaoyu
X
He
Leilei
L
Wu
Jianming
J
Gao
Xiaoping
X
Ren
Jun
J
Li
Ji
J
Can J Physiol Pharmacol. 2007 Nov;85(11):1076-83
18066109
Autophagy. 2008 May;4(4):524-6
18367868
Science. 2004 Mar 26;303(5666):2011-5
14976264
Blood. 2004 Jun 1;103(11):4268-75
14976048
Curr Biol. 2007 Oct 9;17(19):1646-56
17900900
Exp Biol Med (Maywood). 2008 Oct;233(10):1289-300
18641051
Diabetes. 2004 Dec;53(12):3074-81
15561936
J Biol Chem. 2007 Oct 12;282(41):30107-19
17711846
J Nat Prod. 1998 Sep;61(9):1090-5
9748372
Circ Res. 2005 Oct 28;97(9):872-9
16179588
Nature. 2008 Jan 31;451(7178):578-82
18235500
Life Sci. 2004 Apr 16;74(22):2769-79
15043991
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E629-36
12759223
Biochim Biophys Acta. 1996 May 31;1301(1-2):67-75
8652652
J Ethnopharmacol. 1995 Dec 1;49(2):57-68
8847885
Circ Res. 2000 May 12;86(9):1004-7
10807874
Pharmacol Rev. 2007 Dec;59(4):418-58
18048761
Circ Res. 2005 Feb 18;96(3):337-45
15653571
J Biol Chem. 2003 Sep 5;278(36):34003-10
12824177
Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E834-41
15265762
Trends Cardiovasc Med. 2005 Apr;15(3):110-8
16039971
Eur J Biochem. 1997 Jun 1;246(2):259-73
9208914
Diabetologia. 2005 May;48(5):954-66
15834551
Am J Physiol. 1999 Aug;277(2):H643-9
10444490
Bioorg Med Chem. 2006 Feb 15;14(4):1189-98
16214353
Mutat Res. 1993 Sep;319(1):1-9
7690454
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3671-5
2023917
Toxicol Pathol. 2007 Apr;35(3):418-23
17455091
Rejuvenation Res. 2008 Aug;11(4):725-33
18729805
Crit Rev Food Sci Nutr. 1987;26(1):27-135
3308321
Planta Med. 2006 Feb;72(3):222-7
16534726
J Clin Invest. 2004 Aug;114(4):495-503
15314686
J Endocrinol. 2006 Jan;188(1):25-36
16394172